PT Pyridam Farma Tbk (IDX:PYFA)

Market Cap	4.63T +128.9%
Revenue (ttm)	2.82T +109.9%
Net Income	-481.83B
EPS	-60.12
Shares Out	11.24B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	7,429,500
Average Volume	21,437,460
Open	412.00
Previous Close	412.00
Day's Range	398.00 - 412.00
52-Week Range	136.00 - 700.00
Beta	0.93
RSI	44.15
Earnings Date	Apr 7, 2026

About PT Pyridam Farma Tbk

PT Pyridam Farma Tbk engages in the development, production, and trading of pharmaceuticals primarily in Indonesia. The company operates through Pharmaceutical Products, Esthetic, and Toll Manufacturing Services; and Medical Equipments segments. It supplies medical instruments and equipment, including clinical waste, collection swab, collection tube, innerbox DCA, KF94 mask, parafilm, PCR - extraction kit and extractor machine, speciment bag, sterile container, PCR machine- Gentier 48, and tube stopper. The company also provides skin care produ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1976
• Employees: 2,341
• Stock Exchange: Indonesia Stock Exchange
• Ticker Symbol: PYFA

Financial Performance

In 2024, PT Pyridam Farma Tbk's revenue was 1.92 trillion, an increase of 173.59% compared to the previous year's 702.07 billion. Losses were -330.25 billion, 287.5% more than in 2023.